MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurogene (NGNE) Earnings Date & Reports

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning)... Show more

A.I. Advisor
published Earnings

NGNE is expected to report earnings to fall 97.22% to -2 cents per share on November 14

Neurogene NGNE Stock Earnings Reports
Q3'23
Est.
$-0.03
Q1'25
Missed
by $0.01
Q2'23
Est.
$-0.04
Q1'23
Missed
by $0.04
Q4'22
Missed
by $0.05
The last earnings report on May 09 showed earnings per share of -108 cents, missing the estimate of -107 cents. With 335.62K shares outstanding, the current market capitalization sits at 327.60M.
View a ticker or compare two or three
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com